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Abstract
Objective:  this  study  aimed  to  prepare  a  silkworm  moth  (Bombyx  mori)  antigenic  extract  and
to perform  skin  prick  tests  with  this  extract  in  patients  with  allergic  respiratory  diseases;  to
evaluate  serum  speciﬁc  immunoglobulin  E  (IgE)  to  Bombyx  mori  using  ImmunoCAP®  system  and
to  report  the  frequency  of  positivity  between  the  two  methods  and  with  clinical  data.
Methods: this  was  a  cross-sectional  study  with  99  children  and  adolescents  diagnosed  with
asthma and/or  allergic  rhinitis,  who  had  skin  reactivity  to  at  least  one  of  the  six  aeroallergens
tested.  Clinical  data  were  evaluated:  skin  prick  tests  with  Bombyx  mori  in-house  extract,  and
total  and  speciﬁc  IgE  analysis  using  ImmunoCAP®  were  performed.
Results:  the  frequency  of  Bombyx  mori  speciﬁc  IgE  was  found  to  be  52.5%  and  60%  using  the
skin prick  test  and  ImmunoCAP®,  respectively.  An  association  between  a  positive  skin  test  for
Bombyx  mori  and  the  presence  of  allergic  rhinitis,  atopic  dermatitis,  and  urticaria  was  observed,
but  the  same  was  not  true  for  asthma  or  allergic  conjunctivitis.  There  was  no  relation  with  the
severity  of  asthma  or  rhinitis  symptoms.
Conclusions:  a  high  frequency  of  sensitization  to  Bombyx  mori  was  observed  in  a  selected  pop-
ulation of  patients  with  respiratory  allergic  diseases  in  the  city  of  Curitiba,  state  of  Paraná,
Brazil.  The  extract  prepared  from  the  wings  of  this  moth  species  is  effective  in  demonstrating
this  sensitivity.
© 2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
 Please cite this article as: Araujo LM, Rosário Filho NA, Riedi CA. Respiratory allergy to moth: the importance of sensitization to Bombyx
ori in children with asthma and rhinitis. J Pediatr (Rio J). 2014;90:176--81.
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PALAVRAS-CHAVE
Sensibilizac¸ão;
Mariposa;
Asma;
Rinite
Alergia  respiratória  à  mariposa:  importância  da  sensibilizac¸ão  à  Bombyx  mori  em
crianc¸as  com  asma  e  rinite
Resumo
Objetivo:  Preparar  extrato  antigênico  da  mariposa  do  bicho-da-seda  (Bombyx  mori)  e  realizar
testes cutâneos  com  esse  extrato  em  pacientes  com  doenc¸as  respiratórias  alérgicas,  avaliar  IgE
sérica  especíﬁca  para  Bombyx  mori  usando  o  sistema  ImmunoCAP®  e  relatar  a  frequência  de
positividade  entre  os  dois  métodos  e  com  dados  clínicos.
Métodos:  Estudo  transversal  com  99  crianc¸as  e  adolescentes  com  diagnóstico  de  asma  e/ou
rinite alérgica,  que  apresentaram  reac¸ão  cutânea  a  pelo  menos  um  dos  seis  aeroalérgenos
testados. Os  dados  clínicos  foram  avaliados;  testes  cutâneos  com  extrato  de  Bombyx  mori  e
análise  de  IgE  total  e  especíﬁca  por  ImmunoCAP®  foram  realizados.
Resultados:  A  frequência  de  IgE  especíﬁca  para  Bombyx  mori  foi  de  52,5%  e  60%,  respectiva-
mente, pelo  teste  cutâneo  e  ImmunoCAP®.  Foi  observada  uma  associac¸ão  entre  o  teste  cutâneo
positivo  para  Bombyx  mori  e  a  presenc¸a de  rinite  alérgica,  dermatite  atópica  e  urticária,  mas
o  mesmo  não  ocorreu  para  a  asma  ou  conjuntivite  alérgica.  Não  houve  relac¸ão  com  a  gravidade
dos  sintomas  de  asma  ou  rinite.
Conclusões: Alta  frequência  de  sensibilizac¸ão  à  Bombyx  mori  foi  encontrada  em  uma  populac¸ão
selecionada de  pacientes  com  doenc¸as  alérgicas  respiratórias  na  cidade  de  Curitiba,  estado  do
Paraná,  Brasil.  O  extrato  preparado  a  partir  das  asas  dessa  espécie  de  mariposa  é  eﬁcaz  em
demonstrar  essa  sensibilidade.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Sensitization  to  inhalant  allergens  is  a  risk  factor  for  the
development of  allergic  diseases  such  as  asthma  and  rhini-
tis. Knowledge  about  sensitizing  allergens  and  their  degree
of exposure  in  different  environments  is  essential  for  the
diagnosis and  treatment  of  allergic  respiratory  diseases.
Dermatophagoides pteronyssinus  and  Blomia  tropicalis  mites
are the  main  sensitizers  for  patients  diagnosed  with  asthma
and allergic  rhinitis.1,2
The  participation  of  insects  in  allergic  respiratory  reac-
tions has  been  discussed  for  decades.3 The  most  extensively
studied insect  has  been  the  cockroach,  whose  domestic
infestation is  a  cause  of  asthma  and  is  considered  to  be  a
public health  issue.4 There  have  been  descriptions  of  asthma
and rhinitis  triggered  by  species  of  ﬂies  and  mosquitoes  such
as the  mayﬂy  and  the  caddis  ﬂy.5,6 A  study  conducted  with
asthmatic patients  in  the  city  of  São  Paulo,  Brazil,  evidenced
positive skin  prick  test  (SPT)  with  mosquito  extract  in  32.5%
of cases,  and  positive  SPT  with  moth  extract  in  65%  of  cases.7
There  have  been  several  reports  of  individuals  who,
during the  process  of  silk  production,  developed  respira-
tory allergic  diseases.  While  caring  for  silkworm  cocoons,
workers are  exposed  directly  to  their  inhalant  antigens,
present from  the  selection  to  the  hatching  of  cocoons,  when
there is  contact  with  dust  from  the  moths’  wings.8 These
allergens can  trigger  asthma,9 rhinitis,  and  conjunctivitis
symptoms.10
The  silkworm  moth  has  cross-reactivity  with  other
species of  moths  and  butterﬂies;  it  has  been  shown  that
patients with  respiratory  allergic  diseases  can  develop  symp-
toms from  environmental  exposure  to  their  allergens.11,12
Concentrations  of  moth  antigens  veriﬁed  by  radioimmunoas-
say in  samples  of  dust  in  the  external  environment  (not
t
m
come)  for  a  period  of  three  years  were  high  and  at  levels
omparable to  those  of  pollen.
Skin  tests  with  moth  extract  in  allergic  patients  had
5% reactivity  in  this  population.13 In  1997,  allergy  skin
ests in  atopic  children  in  the  city  of  Curitiba,  state  of
araná, Brazil,  detected  38.4%  of  positivity  to  moth  extract
1:20 Heterocera  weight/volume),  the  second  most  frequent
fter the  Dermatophagoides  pteronyssinus  mite  (97.5%).  It
as suggested  that  the  high  rate  of  sensitization  to  moth
equired a  better  evaluation  of  its  clinical  relevance.14
The  aim  of  this  study  was  to  determine  the  sensitivity  to
ombyx mori  by  SPT  using  silkworm  moth  wing  antigens  and
peciﬁc serum  immunoglobulin  E  (IgE)  in  children  diagnosed
ith asthma  and/or  allergic  rhinitis.
ethods
his  was  a  cross-sectional  study  with  non-probabilistic  samp-
ing of  99  children  and  adolescents  of  both  genders  with  a
iagnosis of  asthma  and/or  allergic  rhinitis  treated  at  the
utpatient allergy  clinic  of  Allergy  and  Pediatric  Immunol-
gy Service,  Hospital  de  Clínicas,  Universidade  Federal  do
araná, with  positive  SPT  for  at  least  one  of  the  fol-
owing antigens:  Dermatophagoides  pteronyssinus,  Blomia
ropicalis, Blattella  germanica,  Lolium  multiﬂorum,  dog
pithelium, or  cat  epithelium.
The  diagnosis  and  classiﬁcation  of  respiratory  allergic  dis-
ases (asthma  and  rhinitis)  followed  the  recommendations
f the  Global  Initiative  for  Asthma  (GINA)15 and  Allergic
hinitis and  its  Impact  on  Asthma  (ARIA),16 respectively.The allergen  extract  of  Bombyx  mori  was  prepared  from
he wings  of  this  species  using  the  following  method:  the
aterial from  the  insect  was  macerated  with  a  pestle  in  a
eramic mortar  and  the  content  was  degreased  with  ethyl
1 Araujo  LM  et  al.
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Table  1  Frequency  of  positivity  to  speciﬁc  IgEs  through
Immunocap® (>  0.7  kUA/L)  and  serum  levels  of  speciﬁc  and
total  IgEs.
IgE  (kUA/L)  n  (%)  Median  (min-max)
Blomia  tropicalis  88  (88.9)  17.7  (0  --  >100.0)
Dermatophagoides
pteronyssinus
86  (86.7)  82.4  (0  --  >100.0)
Dermatophagoides
farinae
85  (85.8)  46.2  (0  --  >100.0)
Bombyx  mori 60 (60.6) 1.1  (0  -  >100.0)
Blattella germanica 47 (47.5) 0.6  (0  -- 52.4)
Dog epithelium 22  (22.2) 0.2  (0  -- 31.5)
Cat epithelium  16  (16.2)  0.0  (0  --  71.3)
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ther.  For  antigen  extraction,  the  approximate  amount  of
 g  of  insect  particles  was  placed  in  20  mL  of  cold  sterile
uffer solution  (PBS),  mixed  for  six  minutes,  and  allowed
o stand  for  48  hours  at  8 ◦C.  The  mixture  was  then  cen-
rifuged for  15  minutes  at  12,000  rpm,  and  the  supernatant
as ﬁltered  using  sterile  polyethersulfone  ﬁlters  (Millipore
xpress® PLUS  Membrane  Filters,  USA)  containing  pores  of
.2 micrometers  in  diameters.
After  bacteriological  sterility  tests,  the  ﬁltrate  was
iluted in  50%  glycerin,  1:20  (weight/volume).  This  ﬁnal
oncentration was  chosen  to  allow  for  comparison  with
he results  of  a  similar  study  conducted  in  1997,  in  which
llergy skin  tests  were  performed  with  allergen  extract  stan-
ardized at  1:20  from  Heterocera  sp.  moth  (Hollister-Stier
aboratories®, USA)  in  children  diagnosed  with  asthma  and
llergic rhinitis.14 This  concentration  of  1:20  is  commonly
sed by  manufacturers  of  glycerinated  allergenic  extracts
or SPT.  The  allergen  extract  was  stored  in  bottles  with  a
ropper and  kept  refrigerated  at  4 ◦C.17
All  subjects  underwent  the  SPT  with  the  extract  prepared
rom Bombyx  mori  according  to  the  following  technique:  the
olar surface  of  the  right  forearm  was  cleaned  with  70%  ethyl
lcohol; then,  a  drop  of  the  extract  was  applied  on  the  skin
nd the  location  marked  with  skin  marker  pen.  The  positive
ontrol was  performed  with  histamine  at  a  concentration  of
0 mg/mL  (IPI/ASAC,  Brazil)  and  the  negative  control  with
0% saline/glycerol  (IPI/ASAC,  Brazil)  with  a  3-cm  distance
etween them.  The  puncture  technique  was  used  with  a  27-
m  sterile  needle  applied  superﬁcially  on  the  skin  surface
t an  angle  of  20◦.  After  15  minutes,  the  reading  of  the  reac-
ion was  performed  with  the  aid  of  a  millimeter-scale  ruler.
he test  was  considered  positive  when  the  mean  of  the  two
erpendicular diameters  of  the  papule  was  ≥  3  mm.18
Serum  samples  were  separated  into  aliquots  in  Eppendorf
ubes at  -80 ◦C  until  measurement  of  total  IgE  and  spe-
iﬁc IgE  to  allergens  from  Bombyx  mori,  Dermatophagoides
teronyssinus, Dermatophagoides  farinae,  Blomia  tropicalis,
lattella germanica,  dog  epithelium,  and  cat  epithelium
hrough the  ImmunoCAP®  method.  Each  allergen  was  cova-
ently coupled  to  a  solid  phase  and  reacted  with  speciﬁc  IgE
ntibodies  contained  in  the  serum  sample  of  patients.
In  the  case  of  Bombyx  mori,  the  antigen  coupled  to
he solid  phase  is  derived  from  the  wings  of  this  kind  of
oth, and  the  allergen  components  are  not  available  for
his insect.  Then,  nonspeciﬁc  antibodies  were  removed  by
ashing and  anti-IgE  antibodies  were  added,  bound  to  the
-galactosidase enzyme.  After  incubation,  the  antibodies
anti-IgE-enzyme) that  were  not  bound  were  removed  by
 new  washing  process.  The  enzyme  substrate  contained
n the  development  solution  was  added  to  the  reaction
edium. The  reaction  was  then  discontinued  by  adding  the
top solution,  and  the  ﬂuorescence  was  measured,  which  is
roportional to  the  amount  of  speciﬁc  IgE  in  the  sample.  The
oncentration of  total  IgE  was  expressed  in  kU/L  and  for  the
peciﬁc IgE,  kUA/L.19 Values  >  0.7  kUA/L  were  considered
ositive.
The research  project  was  approved  by  the  Ethics  Commit-
ee on  Human  Research  of  the  HC-UFPR;  parents  or  guardians
igned the  informed  consent  and  participants  older  than  12
ears old  signed  the  term  of  agreement.
For  statistical  analysis,  the  software  program  Statistica
Statsoft®, USA)  was  used.  Measures  of  central  tendency  and
i
i
BTotal  IgE  (kU/L)  -  883.0  (73.9  --  >5,000.0)
ispersion  were  expressed  as  median,  minimum  and  maxi-
um values.  The  nonparametric  Mann-Whitney’s  test  was
sed to  estimate  the  difference  of  variables  with  asymmetric
istribution. The  estimated  difference  between  categorical
ariables was  performed  by  Fisher’s  exact  test  and  the  chi-
quared test.  The  univariate  logistic  regression  model  was
sed to  estimate  the  probability  of  SPT  positivity  according
o the  levels  of  speciﬁc  IgE  to  Bombyx  mori.  A  minimum  level
f signiﬁcance  of  5%  and  a minimum  test  power  of  85%  were
onsidered for  all  tests.
esults
he  mean  age  of  patients  was  10.4  +  2.2  years  with  a  range
f 6-15  years  (95%  CI:  9.9-10.8)  and  61  (61.6%)  were  males.
ighty-seven patients  had  asthma  (87.9%)  and  95  had  (95.9%)
llergic rhinitis;  12  (12.1%)  had  only  rhinitis,  and  four  (4.0%)
ad only  asthma.
Among patients  with  asthma,  31  (35.6%)  were  classi-
ed as  having  the  intermittent  or  persistent  mild  form,  46
52.9%) had  persistent  moderate,  and  ten  (11.5%)  had  per-
istent severe  asthma.  Among  patients  with  allergic  rhinitis,
4 (25.3%)  had  the  mild  form  (intermittent  or  persistent  mild
hinitis)  and  71  (74.7%)  had  persistent  moderate/severe.
Eye  symptoms  (eye  pruritus,  tearing,  conjunctival  hyper-
mia, or  congestion)  were  reported  by  66.7%  of  patients.
mong other  allergic  diseases,  atopic  dermatitis  was  diag-
osed in  nine  (9.1%)  patients  and  urticaria  in  six  (6.1%).
A  positive  reaction  at  SPT  to  the  Bombyx  mori  extract
as observed  in  52  patients  (52.5%),  the  second  in  fre-
uency after  dust  mites;  Dermatophagoides  pteronyssinus,
2 (82.8%),  and  Blomia  tropicalis,  69  (69.7%).  The  other
bserved reactions  were  to  cockroach  (Blattella  german-
ca), dog  epithelium,  rye  grass  (Lolium  multiﬂorum)  pollen,
nd cat  epithelium  with  17.2%,  16.2%,  15.1%,  and  12.1%  of
ositive SPTs,  respectively.
Table  1  shows  the  frequency  of  positive  ImmunoCAP®
ests using  a  cutoff  of  0.7  kUA/L;  the  levels  of  speciﬁc  IgE
nd total  IgE  were  expressed  as  medians  (minimum  and  max-
mum  values).Univariate logistic  regression  analysis  showed  a  good  pos-
tive association  between  SPT  and  levels  of  speciﬁc  IgE  to
ombyx mori  (p  = 0.006).
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Table  2  Association  between  SPT  positivity  for  Bombyx  mori  and  other  skin  tests  (n  =  99).
Allergens  SPT  BOMBYX  +
n =  52  (%)
SPT  BOMBYX  --
n =  47  (%)
p
Dermatophagoides  pteronyssinus  43  (82.7)  39  (83.0)  1.00
Blomia  tropicalis 36 (69.2) 33 (70.2) 1.00
Blattella germanica 08 (15.4) 09 (19.1) 0.79
Lolium multiﬂorum  09  (17.3)  06  (12.8)  0.58
Dog  epithelium  11  (21.1)  05  (10.6)  0.18
Cat  epithelium  08  (15.4)  04  (8.5)  0.36
Fisher’s exact test.
Table  3  Serum  levels  of  total  and  speciﬁc  IgE  according  to  SPT  positivity  for  Bombyx  mori  (n  =  99).
IgE  (kUA/L)  SPT  +
(n =  52)
SPT --
(n  =  47)
p
Dermatophagoides  pteronyssinus  88.8  (0.0  --  146.0)  62.6  (0.0  --  144.0)  0.75
Dermatophagoides  farinae  50.3  (0.0  --  127.0)  36.2  (0.0  --  126.0)  0.77
Blomia  tropicalis  24.2  (0.0  --  113.0)  11.9  (0.0  --  111.0)  0.07
Blattella  germanica  1.0  (0.0  --  52.4)  0.3  (0.0  --  37.3)  0.002
Dog  epithelium  0.2  (0.0  --  6.3)  0.2  (0.0  --  31.5)  0.13
Cat  epithelium  0.0  (0.0  --  71.3)  0.0  (0.0  --  32.5)  0.14
Bombyx  mori  3.1  (0.0  --  100.0)  0.4  (0.0  --  83.0)  <  0.001
Total  IgE  (kU/L)  1107.0  (73.9  --  5,000.0)  772.0  (93.0  --  5,000.0)  0.13
Mann-Whitney’s test
Table  4  Frequency  of  positivity  for  speciﬁc  IgEs  (>  0.7  kUA/L)  according  to  SPT  positivity  for  Bombyx  mori  (n  =  99).
Allergens  SPT  +
n  =  52  (%)
SPT --
n  =  47  (%)
p
Dermatophagoides  pteronyssinus  45  (52.3)  41  (47.7)  1.00
Dermatophagoides  farinae  45  (52.9)  40  (47.1)  1.00
Blomia  tropicalis  48  (54.5)  40  (45.4)  0.34
Blattella  germanica  30  (63.8)  17  (36.2)  0.04
Dog  epithelium  16  (72.7)  06  (27.3)  0.05
Cat  epithelium  11  (68.7)  05  (31.2)  0.18
D
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rBombyx  mori  39  (65.0)  
Fisher’s exact test.
There  was  an  association  between  SPT  positivity  for  Bom-
byx mori  and  the  presence  of  allergic  rhinitis  (p  =  0.04),
atopic dermatitis  (p  =  0.03),  and  urticaria  (p  =  0.02).  How-
ever, there  was  no  association  with  the  presence  of  asthma
(p =  0.36)  and  eye  symptoms  (p  =  0.14).  Likewise,  there  was
no difference  in  the  severity  of  asthma  (p  =  0.73)  or  allergic
rhinitis symptoms  (p  =  0.37).
Regarding  the  frequency  of  positivity  for  Bombyx  mori  in
relation to  other  SPTs,  there  was  no  signiﬁcant  association
(Table 2).
The analysis  of  serum  levels  of  total  and  speciﬁc  IgE  anti-
bodies in  relation  to  the  SPT  for  Bombyx  mori  tended  to
be higher  in  patients  sensitized  to  the  moth.  However,  only
the serum  levels  of  speciﬁc  IgE  to  cockroach  and  to  the
moth were  signiﬁcantly  elevated  in  these  patients  who  were
positive at  the  SPT  for  Bombyx  mori  (Table  3).
There  was  a  signiﬁcantly  higher  frequency  of  positivity
of speciﬁc  IgEs  to  dog  epithelium,  Blattella  germanica,  and
Bombyx mori  (Table  4).
t
K
a21  (35.0)  0.003
iscussion
he  prevalence  of  respiratory  allergic  diseases  has  increased
orldwide in  the  last  decades.20,21 In  Brazil,  the  same
rend of  increase  in  asthma  and  rhinitis  symptoms  has  been
bserved.22 Knowledge  about  sensitizing  aeroallergens  is
ssential for  diagnosis,  treatment,  and  prevention.2
Dust  mites  are  the  main  allergenic  sources  in  patients
ith asthma  and  allergic  rhinitis.23,24 The  importance  of
nsect inhalant  antigens  has  been  discussed  for  decades.3,7 In
his study,  the  moth  was  the  second  most  frequent  aeroal-
ergen regarding  positivity  veriﬁed  by  SPT  and  speciﬁc  IgE
erum levels,  suggesting  that  this  insect  should  be  consid-
red a  sensitizing  agent  for  patients  with  asthma  and  allergic
hinitis.The study  participants  were  not  silk  industry  workers,  and
herefore had  no  occupational  exposure  to  Bombyx  mori.
ino and  Oshima  evaluated  asthmatic  patients  at  random
nd found  sensitivity  to  moth  and  butterﬂy  by  SPT  and
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adioallergosorbent  test  (RAST)  in  the  sera  of  over  one  third
f cases.  The  authors  concluded  that  the  insects  are  easily
ttracted to  the  artiﬁcial  light  of  households  and  may  cause
ensitization and  respiratory  allergy  symptoms.[11]
A  group  of  asthmatics  with  no  history  of  occupational
xposure (n  =  50)  showed  a  frequency  of  positivity  at  the  SPT
or Bombyx  mori  of  68%,12 higher  than  that  observed  in  the
resent patients  (52.5%);  both  studies  used  antigenic  extract
repared from  the  wings  of  moths.  This  difference  may  have
ccurred because  the  population  was  studied  in  Japan,  in
maller numbers,  consisted  of  adults,  and  had  different  life
abits and  exposure  to  different  climate  and  environment.
This  study  showed  an  association  between  SPT  positivity
or Bombyx  mori  and  the  corresponding  speciﬁc  serum  IgE
y ImmunoCAP®,  which  demonstrates  the  effectiveness  of
he extract  made  to  test  sensitization  to  moth.  Moreover,  in
atients with  positive  SPT,  levels  of  speciﬁc  IgE  to  Bombyx
ori were  higher.
When  evaluating  the  frequency  of  positivity  to  speciﬁc  IgE
or moth  according  to  the  severity  of  allergic  rhinitis,  it  was
bserved that  patients  with  more  severe  disease  had  more
ositive serum  speciﬁc  IgEs  for  moth  by  the  RAST  method,25
ifferently  from  that  found  for  the  population  of  the  present
tudy, in  which  there  was  more  positivity  at  the  SPT  for  Bom-
yx mori  in  patients  with  rhinitis;  however,  there  was  no
orrelation with  symptom  severity.  This  difference  may  be
xplained by  the  different  methods  used  to  detect  speciﬁc
gE and  by  the  higher  number  of  participants  in  the  study
onducted in  Japan.
Although the  assessed  population  of  patients  with  atopic
ermatitis and  urticaria  was  small,  more  dermatological
llergic diseases  were  diagnosed  in  those  reactive  to  moth.
his could  be  explored  in  the  future,  as  there  have  been
ew reports  of  allergic  and  irritant  reactions  in  the  skin  after
ontact with  moths.26,27
It  is  known  that  there  is  cross-reactivity  between  insect
llergens. It  was  demonstrated  by  RAST-inhibition  assay  that
here is  cross-reactivity  between  similar  species,  such  as
utterﬂy and  moth,12 but  also  between  different  species,
uch as  moth  and  mosquito.28
The  molecular  allergy  techniques  allowed  for  the  iden-
iﬁcation of  the  major  allergen  of  Bombyx  mori  larvae
Bom m  1),  which  is  constituted  by  arginine  kinase  pro-
ein and  displays  cross-reactivity  with  arginine  kinase
rom the  cockroach.29 In  the  study,  it  was  observed  that
atients reactive  to  Bombyx  mori  at  the  SPT  showed
 higher  frequency  of  positivity  and  higher  levels  of
erum speciﬁc  IgEs  for  Blattella  germanica,  which  could
e explained  by  the  cross-reactivity  between  them.  How-
ver, the  same  did  not  occur  when  comparing  the  positive
kin reactions  between  moth  and  cockroach,  but  the
mmunochemical analysis  of  these  allergens  was  not  per-
ormed.
Moreover, inhibition  tests  with  extracts  from  moth  and
ites showed  differences  between  their  antibodies,  demon-
trating that  there  is  no  cross-reactivity  between  them.12 In
he study,  there  was  no  association  between  the  frequency
f skin  reactivity  at  the  SPT  to  mite  and  moth  antigens
Dermatophagoides  pteronyssinus  and  Blomia  tropicalis).
imilarly, there  was  no  association  between  positivity  at
he SPT  for  Bombyx  mori  and  the  presence  of  speciﬁc
erum IgE  to  mites  (Dermatophagoides  pteronyssinus,Araujo  LM  et  al.
ermatophagoides  farinae,  and  Blomia  tropicalis),  probably
ecause there  is  no  cross-reactivity  between  them.
One  study  from  China  identiﬁed  another  allergen  com-
onent of  Bombyx  mori  (Bom  m  7),  also  obtained  from  the
arvae of  this  insect,  but  consisting  of  tropomyosin  protein.30
t  is  considered  a  pan-allergen,  able  to  show  broad  cross-
eactivity with  components  of  other  insects  such  as  Der  p  10
from the  Dermatophagoides  pteronyssinus  mite)  and  Bla  g 7
from the  Blattella  germanica  cockroach).31,32 Therefore,  to
erify true  allergic  sensitization  or  cross-reactivity,  future
tudies should  be  performed,  based  on  molecular  allergy
iagnosis, but  using  allergenic  components  of  the  Bombyx
ori moth  and  not  of  its  larvae  as  a  cause  of  respiratory
llergic symptoms.33,34
This  study  was  the  ﬁrst  on  sensitization  to  the  silkworm
oth performed  in  Brazil,  and  showed  the  importance  of
ombyx mori  as  a  sensitizing  allergen  in  children  and  adoles-
ents diagnosed  with  allergic  respiratory  diseases  (asthma
nd/or rhinitis).  A  high  frequency  of  sensitization  to  Bom-
yx mori  was  found  in  patients  evaluated  by  SPT  with  an
xtract prepared  from  the  wings  of  moths;  these  results
ere conﬁrmed  by  ImmunoCAP®,  a  well-established  method
or detection  of  speciﬁc  serum  IgE.
The  identiﬁcation  of  this  aeroallergen  (moth),  together
ith the  other  groups  that  compose  the  proﬁle  of  allergic
ensitization in  this  population,  should  make  their  treatment
ore efﬁcient,  as  it  will  allow  for  adjustments  in  environ-
ental control  procedures,  as  well  as  provide  new  speciﬁc
mmunotherapy options  in  the  future.
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